Prevalence of clinical hip abnormalities in haemophilia A and B: An analysis of the UDC database

Haemophilia

Volumn 19, Issue 3, 2013, Pages 426-431

  Kelly, D ^a,d   C Zhang, Q ^b   M Soucie, J ^b   Manco Johnson, M ^c   Dimichele, D ^a,e  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c Mountain States Regional Hemophilia and Thrombosis Center   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Arthropathy; Haemophilia; Hip joint; Joint disease; Target joint

Indexed keywords

ADOLESCENT; ADULT; AGED; ANKLE; ANTIBODY TITER; ARTICLE; CHILD; COMORBIDITY; CORRELATION ANALYSIS; DISEASE REGISTRY; DISEASE SEVERITY; GROUPS BY AGE; HEMOPHILIA A; HEMOPHILIA B; HEMOPHILIC ARTHROPATHY; HIP DISEASE; HUMAN; KNEE DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; HEMOPHILIA A; HEMOPHILIA B; HIP; HUMANS; JOINT DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84876790290     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12073     Document Type: Article

References (22)

1. Wallny T, Brackmann HH, Seuser A, Diedrich O, Kraft CN. Haemophilic arthropathy of the hip in children-prognosis and long-term follow-up. Haemophilia 2003; 9: 197-201.
2. Miles J, Rodríguez-Merchán EC, Goddard NJ. The impact of haemophilia on the success of total hip arthroplasty. Haemophilia 2008; 14: 81-4.
3. Soucie JM, Cianfrini C, Janco RL et al. Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors. Blood 2004; 1: 103.
4. Jansen NWD, Roosendaal G, Lafeber FPJG. Understanding haemophilic arthropathy: an exploration of current open issues. Br J Haematol 2008; 143: 632-40.
5. Manco-Johnson MJ, Abshire TC, Shapiro AD et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 9: 357.
6. Petrini P, Lindvall N, Egberg N, Blombäck M. Prophylaxis with factor concentrates in preventing hemophilic arthropathy. Am J Pediatr Hematol Oncol 1991; 13: 280-7.
7. Aledort LM, Haschmeyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group. J Intern Med 1994; 236: 391-9.
8. Nilsson IM, Berntorp E, Löfqvist T, Pettersson H. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Intern Med 1992; 232: 25-32.
9. Scharrer I, Bray GL, Neutzling O. Incidence of inhibitors in haemophilia A patients-a review of recent studies of recombinant and plasma-derived factor VIII concentrates. Haemophilia 1999; 5: 145-54.
10. Koplan JP, Liverman CT, Kraak VI. Committee on Prevention of Obesity in Children and Youth: preventing childhood obesity: health in the balance: executive summary. J Am Diet Assoc 2005; 105: 131-8.
11. Soucie JM, Wang C, Siddiqi A et al. The longitudinal effect of body adiposity on joint mobility in young males with Haemophilia A. Haemophilia 2011; 17: 196-203.
12. Soucie JM, McAlister S, McClellan A, Oakley M, Su Y. The universal data collection surveillance system for rare bleeding disorders. Am J Prev Med 2010; 38: S475-81.
13. Centers for Disease Control and Prevention (CDC). Blood safety monitoring among persons with bleeding disorders-United States, May 1998-June 2002. MMWR Morb Mortal Wkly Rep 2003; 51: 1152-4.
14. Soucie JM, Wang C, Forsyth A et al. Range of motion measurements: reference values and a database for comparison studies. Haemophilia 2011; 17: 500-7.
15. White GC, Rosendaal F, Aledort LM et al. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 2001; 85: 560.
16. Kuczmarski RJ, Ogden CL, Guo SS et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 2002; 11: 1-190.
17. Valentino LA, Hakobyan N, Enockson C et al. Exploring the biological basis of haemophilic joint disease: experimental studies. Haemophilia 2012; 18: 310-8.
18. Tagariello G, Iorio A, Santagostino E et al. Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders. Blood 2009; 23: 114.
19. Ogden CL, Carroll MD, Flegal KM. High body mass index for age among US children and adolescents, 2003-2006. JAMA 2008; 299: 2401-5.
20. Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes 2006; 1: 11-25.
21. Perry DC, Hall AJ. The epidemiology and etiology of Perthes disease. Orthop Clin North Am 2011; 42: 279-83. v.
22. Dauty M, Sigaud M, Trossaërt M, Fressinaud E, Letenneur J, Dubois C. Iliopsoas hematoma in patients with hemophilia: a single-center study. Joint Bone Spine 2007; 74: 179-83.